-
Site of Care Cost-Effectiveness of Axicabtagene Ciloleucel in Relapsed/Refractory Second-Line or Later Large B-cell Lymphoma in the United States: Analyses for Inpatient and Outpatient Infusion Settings
Sep 9, 2025, 16:22 PM -
Get Real: A How-to Framework on Designing and Implementing a Regulatory and HTA-Grade External Comparator Study
Sep 9, 2025, 16:22 PM -
AI in Pragmatic Literature Reviews: A Scoping Review of Current Guidance and Development of a Framework for Integration
Sep 9, 2025, 16:22 PM -
Generating Data for Diversity Planning in Breast Cancer: A Multi-Database Validation Study Using US Claims and HER, Population Census, and Cancer Registry Data in the United States
Sep 9, 2025, 16:22 PM -
Innovation on Hold: A 2020-2025 Analysis of the Conditional Drug Reimbursement Framework
Sep 9, 2025, 16:22 PM -
Comprehensive Uncertainty Assessment in Economic Evaluations of AI-Based Health Technologies: Pitfalls and Recommendations
Sep 9, 2025, 16:22 PM -
The PHEBUS Study: A Retrospective Analysis of the Burden of Pneumococcal Infections in the Pediatric Population Using the French Hospital Discharge Database (PMSI)
Sep 9, 2025, 16:22 PM -
The Economic Case for Gender Equity: How Closing the Women’s Health Gap Benefits Healthcare Systems and Economies
Sep 9, 2025, 16:22 PM -
From Evidence to Enforcement? Implications of the 2025 SVR Report for Pharmaceutical Pricing and Orphan Drug Policy in Germany
Sep 9, 2025, 16:22 PM -
Assessment of Health State Utilities Associated With Treatment for Chronic Hepatitis B Virus (HBV) Infection
Sep 9, 2025, 16:22 PM -
HTA Readiness for Tumor-Agnostic Therapies: Lessons From Analogues Across Major Markets
Sep 9, 2025, 16:22 PM -
Clinical Benefit vs. Reimbursement Decisions: Examining Misalignments Between ESMO-MCBS and HTA Outcomes in Oncology
Sep 9, 2025, 16:22 PM -
Balancing Fit and Accuracy: Evaluating Survival Model Projections With Immature Data in Health Technology Assessments
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Ocrelizumab for Treating Relapsing Multiple Sclerosis in Austria
Sep 9, 2025, 16:22 PM -
Reducing External Plasma Dependency: Impact for the Portuguese National Health Service
Sep 9, 2025, 16:22 PM -
Clinical and Economic Perspectives on Influenza and COVID-19 Vaccine Combinations
Sep 9, 2025, 16:22 PM -
Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan
Sep 9, 2025, 16:22 PM -
Can Intravitreal Aflibercept 8 mg Result in Decreased Treatment Burden and Treatment Costs in European Patients With Age-Related Macular Degeneration? Early Evidence From Clinical Practice
Sep 9, 2025, 16:22 PM -
AI-Assisted Systematic Literature Screening According to NICE, UK, and CDA (Canada) Position Papers: An HTA Submission Use Case
Sep 9, 2025, 16:22 PM
